1. Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): Initial validation and practical use. British Journal of Dermatology 1995; 132: 942-949.
2. Finlay AY, Coles EC, Lewis-Jones MS, Blackford S, Holt PJA, Howard A, Knight AG, Lanigan SW, Logan RA, Long CC, Marks R, Motley RJ, Roberts DLL, Statham BN, Wilkins J. Quality of life improves after seeing a dermatologist. British Journal of Dermatology 1998; 139 (Suppl 51): 15.
3. Ahmed I, Berth-Jones J, Friedmann P, Graham-Brown R, Cork M, Sowden J, Finlay A, Beard A, Sumner M, Harper JI. Short course versus continuous course therapy of cyclosporin in severe childhood atopic dermatitis. British Journal of Dermatology 1998; 139 (Suppl 51): 22.
4. Emerson RM, Lawson S, Williams HC. Do specialist eczema clinics benefit children with atopic dermatitis. British Journal of Dermatology 1998; 139 (Suppl 51): 46.
13. Titman P S, Barker C, Smith C H. The psychological impact of chronic eczema on children and families. Br J Dermatol 2001; 145 (Suppl 59): 128-129.
14. Chaudhry S, Moss C, Gilmour E. Quality of life measurements in children with atopic eczema from different ethnic groups in Birmingham. Br J Dermatol 2001; 145 (Suppl 59): 45.
15.
Poyner TF, Sibley G, Chim DJ. The effects of
a nurse-run clinic in primary care on the quality of life of children with
atopic eczema. Br J Dermatol 2001; 145:
(Suppl 59): 22.
16. Ben-Gashir MA, Seed P T, Hay RJ. Quality of life and disease severity are correlated in children with atopic eczema. JEADV 2001; 15 (Suppl 2): 111.
17. Eiser C, Morse R. Quality of life measures in chronic diseases of childhood. Health Technol Assess 2001; 5(4): pages 31, 35, 37, 43, 143.
18. Hanifin J, Allen R, De Prost Y, Luger T. Validation of the eczema area and severity index (EASI) for atopic dermatitis in 1,533 patients from the pimecrolimus 1% cream clinical programme. Ann Dermatol Venereol 2002; 129: 1S411.
19. Verboom P, Hakkaart-Van Roijen L. The cost effectiveness of pimecrolimus (SDZ ASM 981) topical cream 1% and corticosteriods in the treatment of atopic dermatitis. Ann Dermatol Venereol 2002; 129: 1S425.
20. Chinn D J, Poyner T Sibley G. Randomised controlled trial of a single dermatology nurse consultant in primary care on the quality of life of children with atopic eczema. Br J Dermatol 2002; 146: 432-439.
21. Whalley D, McKenna S, Huels J, Van Assche D. Pimecrolimus (SDZ ASM 981) in the treatment of paediatric atopic eczema: Benefit to quality of life and health-related quality of life. Ann Dermatol Venereol 2002; 129: 1S426.
22.
Taieb C, Nocera T, Verriere F, Martinsic M A,
Bouissou P, Myon E. Impact of skin diseases on the quality of life of
children and their parents. JEADV 2002; 16
(Suppl 1): 267.
23.
Aziah M S, Rosnah T, Mardziah A, Norzila M Z.
Childhood atopic dermatitis: a measurement of quality of life and family
impact. Med J Malaysia 2002; 57:
329-39.
24.
Fivenson D, Arnold R J G, Kaniecki D J, Cohen J L,
Frech F, Finlay A Y. The effect of atopic dermatitis on total burden of
illness and quality of life on adults and children in a large managed care
organisation. J Managed Care Pharmacy 2002;
8 (5): 333-342
25. Horn H M, Tidman M J. Quality of life in epidermolysis bullosa. Clin Exp Dermatol 2002; 27(8): 707-710.
26. Holme S A, Mann I, Sharpe J L, Dykes P J, Lewis-Jones M S, Finlay A Y. The Childrens’ Dermatology Life Quality Index: validation of the cartoon version. Br J Dermatol 2003; 148: 285-290.
27.
Beattie P E & Lewis-Jones M S. Impairment of
quality of life in children with skin disease: further validation studies of
the Children's Dermatology life quality Index and the Children's Life quality
Index. Br J Dermatol 2003; 149
(Suppl 64): 77-78.
28.
Fleckman P, Hamill G, Weinstock M A. The
National Registry for Ichthyosis and Related disorders - health related quality
of life and patient reported outcomes.
J Invest Dermatol 2003; 121(1): 0420.
29. Taieb C, Verriere F, Nocera T, Myon E. Impact of hydrotherapy care on the quality of life of children. JEADV 2003; 17 (Suppl 3): 336.
30. Chuh A T A. Quality of life in children with pityriasis rosea: a prospective case control study. Pediatric Dermatology 2003; 20 No 6: 474-478.
31. Chuh A T A. Validation of a Cantonese version of the Children’s Dermatology Life Quality Index. Pediatric Dermatology 2003; 20 No 6: 479-481.
32. Nocera T, Veriere F, Myon E, Taieb C. Impact of hydrotherapy care on the quality of life of children. Quality of Life Research 2003; 12: 777.
33. Charman C, Chambers C Williams H. Measuring atopic dermatitis severity in randomized controlled clinical trials: what exactly are we measuring? JID 2003; 120 (6): 932-941.
34. Won C, Seo P, Park Y, Yang J, Lee K, Sung K, Park C, Kim D, Change H, Won Y Kim K. A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea. J Dermatolog Treat 2004; 15(1): 30-34.
35. Grad O, Niren N, Sung J, Law A. Impact of atopic dermatitis treatment on quality of life: Results from findings in atopic children with eczema (face) study. J Am Acad Dermatol 2004; 50(3): P65.
36. Ben-Gashir M A, Seed P T, Hay R J. Quality of life and disease severity are correlated in children with atopic dermatitis. BJD 2004; 150: 284-290.
37. Austin E, Phillips G, Lewis-Jones S. The prevalence of fusidic acid-resistant Staphylococcus aureus colonization in paediatric outpatients with atopic dermatitis. BJD 2004; 151 (Suppl 68):74.
38. Woo P N, White M I. A family study of erythrokeratoderma variabilis. BJD 2004; 151 (Suppl 68): 71.
39. Charman C R, Venn A J, Williams H C. The patient-orientated eczema measure - development and validation of anew tool for measuring atopic eczema severity from the patients’ perspective. Pead Dermatol 2004; 21 (3): 337. Arch Dermatol 2004; 140: 1513-1519.
40. Finlay A Y, Myon E, Martin N, Verriere F, Taiebl Ch. Impact of thermal spa on children’s quality of life. JEADV 2004; 18 (Suppl 2) 310.
41. Holm E A, Esmann S, Jemec. Patient Education and morbidity in atopic eczema. Dermatol Nursing 2005; 17(1): 35-45.
42. Weber M, Mazzotti N, Barzenski B, Silva T. Evaluation of the quality of life in patients with atopic dermatitis participating in support groups. J Am Acad Dermatol 2005; 52 (Suppl 1): 70.
43. Blanchet-Bardon C, Corre J-M, Le C N. Health-related quality of life in ichthyosis patients and family members. J Am Acad Dermatol 2005; 52(Suppl 1): 110.
44. Agredano Y, Alster T S, Bryan H A, Weiss S C. Quality of life assessment of patients with port-wine stains receiving flashlamp-pulsed dye laser treatment. J Am Acad Dermatol 2005; 52(Suppl 1):
45.
Holme S A, Anstey A V, Badminton M N, Elder G H.
UK prospective study on erythropoietic protoporphyria: quality of life
assessment. BJD 2005; 153
(Suppl 1): 41.
46. Baron S E, Layton A, Goulden V. A pilot study of hypnotherapy to treat adults and children with moderate to severe atopic dermatitis. BJD 2005; 153 (Suppl 1): 37.
47. Charman C R, Venn A J, Williams H, Bigby M. Measuring atopic eczema severity visually. Arch Dermatol: 2005; 141: 1146-1151.
48. McKenna S p, Whalley D, de Prost Y, Staab D, Huels S J, Paul C F, van Assche D. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel®, SDZ ASM 981): impact on quality of life and health-related quality of life. JEADV 2006; 20: 248-254.
49. Baron S, Layton A, Goulden V. A Pilot study of hypnotherapy to treat adults and children with moderate to sever atopic dermatitis. J Am Acad Dermatol 2006; 54: AB2
50. Shaw M, Goldsmith L, Morell D. The study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD). J Am Acad Dermatol 2006; 54: AB83
51 Weber M B, Soirefmann M, Mazzotti N G, Cestari T F. Improvement of pruritus, clinical manifestations and quality of life of patients with atopic dermatitis and their families after joining support groups. J Am Acad Dermatol 2006; 54: AB87.
52 Holm E A, Wulf H C, Stegmann H, Jemec G B E. Life quality assessment among patients with atopic eczema. BJD 2006; 54: 719-725.
53 Beattie P E, Lewis-Jones M S. A comparative study of impairment of quality of life in children with skin diseases and children with other chronic child diseases. BJD 2006 155: 145-151.
54
Hon K L E, Lam M C A, Kam W Y C, Leung T F, Wong K
Y, Lee K K C, Fok T F,
Ng P C. CDLQI, SCORAD and NESS: are they correlated? BJD 2006
155: 106-119.
55 Sunderkotter C, Weiss J M, Bextermoller R. :Loffler ,. Schneider D. Post-market surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life. J Dtsch Dermatol Ges 2006; 4: 301-306.
56 Holme S A, Anstey A V, Finlay A Y, Elder G H, Badminton M N. Erythropoietic protoporphyria in the UK: clinical features and effect on qualify of life. BJD 2006; 155: 574-581.
57 Hon K L E, Kam W Y C, Lam M C A, Leung T F, Ng P C. CDLQI, SCORAD and NESS: are they correlated? Quality of Life Research 2006; 15: 1551-1558.
58 Walker N, Lewis-Jones M S. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children’s Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI). J Eur Acad Dermatol Venereol 2006; 20: 45-50.
59 P.E. Beattie* and M.S. Lewis-Jones. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006; 155: 145-151.
60 Ganemo A, Svensson A, Lindberg M, Wahlgren C-F. Quality of life in Swedish children with eczema. Acta Derm Venereol 2007; 87:345-349.
61 Hon K L E, Leung T F, Ng P C, Lam M C A, Kam W Y C, Wong K Y, Lee K C K, Sung Y T, Cheng K F, Fok T F, Fung K P, Leung P C. Efficacy and tolerability of a Chinese herbal medicine concoction for treatment of atopic dermatitis: a randomized, double-blind, placebo-controlled study. Br J Dermatol 2007; 157: 357-363.
62 Clayton T H, Clark S M, Britton J, Pavolv S, Radev S. A comparative study of the Children’s Dermatology Life Quality Index (CDLQI) in paediatric dermatology clinics in the UK and Bulgaria. JEADV 2007; 21: 1436-1437
63 Taieb C, Martinsic M A, Nocera T, Bousetta S. Atopic dermatitis and thermal therapies: evaluation in children under 15. J Am Acad Dermatol 2008; P2314.
64 Shaw M, Morrell D S, Goldsmith L A. A Study of Targeted Enhanced Patient care for Pediatric Atopic Dermatitis (STEP PAD). Pediatric Dermatology 2008; 25: 19-24.